NYU Langone Health
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, NYU Langone Health sits in the top decile of US sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count).
NYU Langone Health: 1,164 sponsored US clinical trials, 197 recruiting.
NYU Langone Health sponsors 1,164 registered US clinical trials on ClinicalTrials.gov, 197 of them currently recruiting, and 741 completed. 123 of these trials are in Phase 3-4 (later-stage) and 231 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 12 trials.
Top-decile sponsor footprint
NYU Langone Health ranks in the top decile of sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
741 of 866 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,164 total, page 17 of 24
Sphenopalatine Ganglion Block to Treat Shoulder Pain After Thoracotomy
NCT02733393
Carbidopa for the Treatment of Excessive Blood Pressure Variability
NCT02553265
Brain Ion Homeostasis, Lithium and Bipolar Disorder
NCT02727127
Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease
NCT02646488
Implementing Tobacco Use Guidelines in Community Health Centers in Vietnam Public Health System
NCT02564653
Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users
NCT02445339
Financial Incentives for Smoking Treatment
NCT02506829
Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY
NCT02665221
Capnometry-Assisted Breathing Training for COPD
NCT03457103
Evaluation Of The Pan-microbiome and Host Immune Response in CF
NCT02778750
Evaluation of a Wearable Exoskeleton for Functional Arm Training
NCT02726204
Feasibility of Telephone Follow-up Visits in Primary Care
NCT02393534
RCT- Comparing Testimonial Versus Documentary Organ Donation Video Education
NCT02836301
Enhancing Management of Chronic Pain and Symptoms Among Women Treated for Breast Cancer (Lymph-Flow)
NCT02462226
Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy
NCT02628964
Implementation and Evaluation of Care Coordination in Linkage to Care for Hepatitis C Following Release From New York City Jails
NCT04036760
Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyopathy
NCT02657967
Multinight CPAP for Sleep Apnea Patients
NCT02635100
Evaluating the Use of Tranexamic Acid (TXA) in Total Joint Arthroplasty
NCT03825939
Efficacy of AposTherapy® in Knee OA
NCT03153956
The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals
NCT02421263
Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate Cancer
NCT02459912
Integrated Clinical Prediction Rules: Bringing Evidence to Diverse Primary Care Settings
NCT02534987
Apparent Life Threatening Events in Infants
NCT02779062
Ultrasound Guided Sciatic Nerve Block
NCT02688439
A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients
NCT02665208
The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation
NCT02707380
Determination of TOF Test Threshold for Obtaining Reliable Pedicle Screw Stimulation Test During Lumbar Spine Surgery
NCT02285829
Organizational Skill Training (OST) in Schools
NCT02663986
Relationship Between Diet, Lifestyle, and the Severity of Coronary Artery Disease
NCT02382250
RCT Comparing Tailored Versus Targeted Organ Donation Video Education
NCT02676102
Antiplatelet Therapy in HIV
NCT02559414
Medipore Tape Study
NCT02676115
Effectiveness of Astym Treatment For de Quervain's Tenosynovitis
NCT02442622
Stationary Bike Study
NCT02640599
Comparing Unimanual and Bimanual Mirror Therapy for Upper Limb Recovery Post Stroke
NCT02780440
Lifestyle Management of CKD in Obese Diabetic Patients
NCT02276742
Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy
NCT02452060
Making Sense of Dyspnea Assessment
NCT02771262
MRI-Targeted Focal Ablation of the Prostate in Men With Prostate Cancer
NCT02303054
Kappa Opioid Receptor Imaging in Anorexia
NCT02240797
Geography of ED Use and Population Health
NCT03254524
Impact of Gastroesophageal Reflux and Aspiration on Airway Inflammation and Microbiome in Children With Chronic Cough
NCT02797756
Functional Outcomes After Radial Head Fractures Treated Non-operatively
NCT03170128
High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy
NCT02264652
Changes in Ischemia and Angina Over 1 Year Among ISCHEMIA Trial Screen Failures With no Obstructive CAD on Coronary CT Angiography
NCT02347215
A Comparison of Intra-op Ketamine vs Placebo in Patients Having Spinal Fusion
NCT02424591
Cutaneous and Systemic Reactions to Metal Implants
NCT02483728
Kappa Opioid Receptor Imaging in Depression (KOR Depression)
NCT02236702
Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)
NCT02221739
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 99 |
| Phase 2 | 132 |
| Phase 3 | 28 |
| Phase 4 | 95 |
Therapeutic Areas
What is open in the NYU Langone Health pipeline
197 recruiting of 1,164 indexed (17% open); 741 completed (64%).
Phase mix: 123 late (III/IV) vs 231 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
NYU Langone Health: open-pipeline peers nationwide
Peers matched on 1,164 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
NYU Langone Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,164 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 17% open enrollment (± trial volume)
- CSL Behring · 17% recruiting · 71 trials
- Penn State University · 17% recruiting · 219 trials
- University of Hawaii · 17% recruiting · 77 trials
- University of Utah · 17% recruiting · 818 trials
Related
What to do with this NYU Langone Health page
1,164 registered trials is a research-attention snapshot, not an endorsement of NYU Langone Health or any single study.
- 197 of NYU Langone Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition NYU Langone Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
NYU Langone Health pipeline card: 1,164 registered trials from official public datasets.Report a data error.